Stock-Based Compensation

$103.19K

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$103.19Kperiod endingJun 30, 2026

APRE Quarterly Stock-Based Comp ($79.79K → $103.19K)

Quarterly stock-based compensation

High-resolution chart · PNG

APRE stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Stock-Based Compensation — Quarterly (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	103,193
Mar 31, 2026	101,068
Dec 31, 2025	109,024
Sep 30, 2025	113,754
Jun 30, 2025	136,729
Mar 31, 2025	118,634
Dec 31, 2024	126,028
Sep 30, 2024	149,090
Jun 30, 2024	128,488
Mar 31, 2024	85,830
Dec 31, 2023	82,861
Sep 30, 2023	76,031
Jun 30, 2023	269,323
Mar 31, 2023	16,244
Dec 31, 2022	57,355
Sep 30, 2022	38,236
Jun 30, 2022	14,801,615
Mar 31, 2022	2,084,060
Dec 31, 2021	2,091,092
Sep 30, 2021	2,036,591
Jun 30, 2021	1,863,498
Mar 31, 2021	1,822,562
Dec 31, 2020	1,431,445
Sep 30, 2020	0
Jun 30, 2020	1,256,460
Mar 31, 2020	905,471
Dec 31, 2019	0
Sep 30, 2019	246,225
Jun 30, 2019	186,963
Mar 31, 2019	97,946
Dec 31, 2018	79,539
Sep 30, 2018	79,791